LAB: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, LAB has $639,114K in assets. $77,991K in debts. $265,772K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1235.58%
Quick Ratio
1191.52%
Cash Ratio
629.75%
Debt to Asset Ratio
12.20%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Short-term investments
Long-term investments
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Treasury stock at cost 18,580 sh...
Others

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	265,772	120,863	129,418	158,617
Short-term investments	189,404	66,712	65,485	78,468
Accounts receivable, net	16,637	13,431	13,536	14,612
Inventory	18,594	19,981	25,418	24,170
Prepaid expenses and other current assets	6,046	4,871	7,906	7,081
Contingent consideration receivable	25,000	-	-	-
Current assets held for sale	0	228,406	230,676	223,089
Total current assets	521,453	454,264	472,439	506,037
Property and equipment, gross	65,310	66,537	67,438	-
Less accumulated depreciation and amortization	49,030	48,162	47,075	-
Construction-in-progress	823	900	375	-
Property and equipment, net	17,103	19,275	20,738	22,678
Operating lease right-of-use asset, net	25,545	26,732	23,453	24,568
Other non-current assets	3,386	3,154	3,521	3,682
Long-term investments	71,357	25,701	19,485	-
Deferred tax asset, non-current	270	38,628	-	-
Non-current assets held for sale	-	0	0	0
Total assets	639,114	567,754	539,636	556,965

Accounts payable	8,007	5,407	6,619	7,329
Accrued liabilities	15,684	29,783	30,810	24,207
Operating lease liabilities, current	5,540	5,490	5,113	5,094
Deferred revenue, current	9,981	38,949	40,111	40,167
Deferred grant income, current	2,991	3,046	3,098	3,243
Current liabilities held for sale	0	25,633	22,214	17,984
Total current liabilities	42,203	108,308	107,965	98,024
Non-current liabilities held for sale	-	-	0	0
Convertible notes, non-current	299	299	299	299
Deferred tax liability	823	810	1,139	1,081
Operating lease liabilities, non-current	23,652	25,038	21,977	23,223
Deferred revenue, non-current	3,013	3,503	2,366	2,786
Deferred grant income, non-current	3,557	4,290	5,031	5,767
Other non-current liabilities	4,444	1,215	1,200	1,250
Total liabilities	77,991	143,463	139,977	132,430
Common stock 0.001 par value, 600,000 shares authorized at march 31, 2026 and december 31, 2025 408,722 and 404,961 shares issued at march 31, 2026 and december 31, 2025, respectively 390,141 and 386,381 shares outstanding at march 31, 2026 and december 31, 2025, respectively	408	404	401	400
Additional paid-in capital	1,741,172	1,732,393	1,726,032	1,717,673
Accumulated other comprehensive income (loss)	-511	-1,492	-477	-1,928
Accumulated deficit	-1,133,479	-1,260,547	-1,279,830	-1,245,143
Treasury stock at cost 18,580 shares at march 31, 2026 and december 31, 2025	46,467	46,467	46,467	46,467
Total stockholders' equity	561,123	424,291	399,659	424,535
Total liabilities and stockholders' equity	639,114	567,754	539,636	556,965

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets